Structure Therapeutics (GPCR) Stock: Buy, Sell, or Hold?
GPCR - Structure Therapeutics Inc. American Depositary Shares
$21.87
-0.07 (-0.32%)
▼
5d:
+3.21%
30d:
-24.53%
90d:
-54.78%
BUY
HIGH Confidence
Analysis Updated: Oct 30, 2026 12:00 AM ET
Earnings: Nov 05, 2026
3d
Get Alerted When GPCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: GPCR shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: GPCR shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: GPCR is currently trading at $21.87, which is considered slightly low relative to its 30-day fair value range of $20.84 to $31.00.
Technical Outlook: Technically, GPCR is in a strong downtrend. Immediate support is located at $20.50, while resistance sits at $23.83.
Market Sentiment: GPCR scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $107.29 (+390.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GPCR is in a strong downtrend. Immediate support is located at $20.50, while resistance sits at $23.83.
Market Sentiment: GPCR scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $107.29 (+390.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$20.84 -
$31.00
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 390.6% below Wall St target ($107.29)
- BULLISH: Bottoming setup score 75/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$20.84 -
$31.00
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$20.50
Resistance Level
$23.83
Current Trend
Strong Downtrend
Technical data as of
Oct 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.01
Wall Street Target
$107.29
(+390.6%)
Share & Embed Analysis
Last updated: November 01, 2026 4:05 PM ET
Data refreshes hourly during market hours. Next update: 5:05 PM
Data refreshes hourly during market hours. Next update: 5:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GPCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$259 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 56 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 43 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$37 | 67 BUY |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 47 HOLD |
